A series of Japanese studies from a liver cancer center showed that 19% of patients with ICC had serum AFP levels > 20 ng/mL, 10.3% of them had >200 ng/mL, while serum AFP levels > 1000 ng/mL was recorded in 6.3% of the cases [26]. The gene discussed is AFP; the disease is liver cancer.